Published in Int J Tuberc Lung Dis on April 09, 2012
Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial. Clin Infect Dis (2014) 1.11
The role of costotransverse radical debridement, fusion and postural drainage in the surgical treatment of multisegmental thoracic spinal tuberculosis: a minimum 5-year follow-up. Eur Spine J (2015) 0.77
Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet (2007) 9.71
Antiretroviral therapy in a thousand patients with AIDS in Haiti. N Engl J Med (2005) 8.13
A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med (2004) 5.68
Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet (1993) 5.24
American Thoracic Society. Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis (1990) 4.29
Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial. Lancet (2000) 2.77
Tuberculosis retreatment category predicts resistance in hospitalized retreatment patients in a high HIV prevalence area. Int J Tuberc Lung Dis (2009) 2.22
5-year survival of patients with AIDS receiving antiretroviral therapy in Haiti. N Engl J Med (2009) 2.21
Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study. PLoS Med (2011) 1.68
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol (1986) 37.70
Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science (1986) 11.74
Integration of cytogenetic landmarks into the draft sequence of the human genome. Nature (2001) 10.96
Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science (1999) 7.84
Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet (2001) 7.31
Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus. J Exp Med (1986) 6.52
No effect of isoniazid prophylaxis for purified protein derivative-negative HIV-infected adults living in a country with endemic tuberculosis: results of a randomized trial. J Acquir Immune Defic Syndr (2001) 6.23
A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc Natl Acad Sci U S A (1991) 6.13
Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line. Nature (1982) 6.11
Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood (1979) 6.01
Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet (1997) 5.54
Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet (2000) 5.42
Ecological forecasts: an emerging imperative. Science (2001) 5.18
Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody. J Virol (1992) 4.72
Cloning of the cDNA for the human beta 1-adrenergic receptor. Proc Natl Acad Sci U S A (1987) 4.66
Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science (1997) 4.57
Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J Infect Dis (1997) 3.88
Characteristics of the acquired immunodeficiency syndrome (AIDS) in Haiti. N Engl J Med (1983) 3.61
Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature (1990) 3.50
Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D. J Virol (1994) 3.33
An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature (1987) 3.33
Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology (2000) 3.03
Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. J Exp Med (1993) 2.96
Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus. J Virol (1987) 2.84
Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial. Lancet (2000) 2.77
Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect Immun (2001) 2.68
The Rapid Syndrome Validation Project (RSVP). Proc AMIA Symp (2001) 2.67
Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development. Genes Dev (1994) 2.39
Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J Infect Dis (2000) 2.37
Uncoupling protein 2, in vivo distribution, induction upon oxidative stress, and evidence for translational regulation. J Biol Chem (2000) 2.36
Genetic diversity of Borrelia burgdorferi in lyme disease patients as determined by culture versus direct PCR with clinical specimens. J Clin Microbiol (1999) 2.35
NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann Intern Med (1991) 2.15
Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population. J Immunol (1990) 2.05
Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia (2000) 2.02
HIV infection in Haiti: natural history and disease progression. AIDS (2000) 1.97
Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis. Infect Immun (2001) 1.97
High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. J Exp Med (1993) 1.97
International differences in survival from colon cancer: more effective care versus less complete cancer registration. Br J Surg (1998) 1.97
Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain (2004) 1.96
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Med (2003) 1.94
Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol (1995) 1.91
Integration of tuberculosis screening at an HIV voluntary counselling and testing centre in Haiti. AIDS (2001) 1.90
beta-Adrenergic activation of p38 MAP kinase in adipocytes: cAMP induction of the uncoupling protein 1 (UCP1) gene requires p38 MAP kinase. J Biol Chem (2001) 1.89
CD8+ T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity. Proc Natl Acad Sci U S A (1990) 1.88
Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand (2008) 1.88
Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology (2005) 1.88
The clinical and economic impact of deep chest surgical site infections following coronary artery bypass graft surgery. Chest (2000) 1.85
Phrenic nerve conduction study in normal subjects. Muscle Nerve (1995) 1.80
Promoting uptake of influenza vaccination among health care workers: a randomized controlled trial. J Public Health Med (2001) 1.78
Conversation analysis: a method for research into interactions between patients and health-care professionals. Health Expect (2001) 1.72
Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi. Nature (1994) 1.69
Quantitative disassembly and reassembly of human papillomavirus type 11 viruslike particles in vitro. J Virol (1998) 1.67
Pruritic skin lesions. A common initial presentation of acquired immunodeficiency syndrome. Arch Dermatol (1989) 1.66
The natural history of human immunodeficiency virus 1 infection in Haitian infants. Pediatr Infect Dis J (1999) 1.64
Serum mannose-binding lectin deficiency is associated with cryptosporidiosis in young Haitian children. Clin Infect Dis (2006) 1.64
Heterosexual transmission of HIV in Haiti. Ann Intern Med (1996) 1.62
Identification of HIV vaccine candidate peptides by screening random phage epitope libraries. Virology (1993) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes. Diabetologia (2010) 1.60
Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice. J Pain Symptom Manage (2000) 1.59
Health prevention messages may have paradoxical effect. BMJ (1993) 1.59
Are differences in stage at presentation a credible explanation for reported differences in the survival of patients with colorectal cancer in Europe? Br J Cancer (2001) 1.58
Clinical manifestations and therapy of Isospora belli infection in patients with the acquired immunodeficiency syndrome. N Engl J Med (1986) 1.56
Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A. J Exp Med (1994) 1.55
A prospective study of HIV-seropositive asymptomatic women of childbearing age in a developing country. J Acquir Immune Defic Syndr (1993) 1.55
Diagnostic screening of mitochondrial DNA mutations in Australian adults 1990-2001. Intern Med J (2004) 1.53
Characterization of a major neutralizing epitope on human papillomavirus type 16 L1. J Virol (1999) 1.52
Influence of volume of work on the outcome of treatment for patients with colorectal cancer. Br J Surg (1999) 1.49
Diet-induced changes in uncoupling proteins in obesity-prone and obesity-resistant strains of mice. Proc Natl Acad Sci U S A (1998) 1.49
Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations. J Med Genet (1998) 1.47
Two distinct pathways for cAMP-mediated down-regulation of the beta 2-adrenergic receptor. Phosphorylation of the receptor and regulation of its mRNA level. J Biol Chem (1989) 1.45
Failure of cricopharyngeal myotomy to improve dysphagia following head and neck cancer surgery. Arch Otolaryngol Head Neck Surg (1999) 1.45
Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet (1999) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Characterization of a conserved T cell epitope in HIV-1 gp41 recognized by vaccine-induced human cytolytic T cells. J Immunol (1991) 1.38
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Agriculture policy. EU agricultural reform fails on biodiversity. Science (2014) 1.34
Characterization of GP120 binding to CD4 and an assay that measures ability of sera to inhibit this binding. J Immunol (1988) 1.34
A multi-centre evaluation of nine rapid, point-of-care syphilis tests using archived sera. Sex Transm Infect (2006) 1.33
A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous, cell-free simian immunodeficiency virus challenge. J Virol (1995) 1.33
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Novel prion protein insert mutation associated with prolonged neurodegenerative illness. Neurology (2003) 1.31
Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys. J Immunol (1993) 1.30
Structural abnormalities of the nervous system in Crohn's disease and ulcerative colitis. Neurogastroenterol Motil (1998) 1.29
What changes in the organisation of cancer services will improve the outcome for women with ovarian cancer? Br J Obstet Gynaecol (1997) 1.29
Macrophage factor controlling differentiation of B cells. J Immunol (1979) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev (2005) 1.27
Expression of three alpha 2-adrenergic receptor subtypes in rat tissues: implications for alpha 2 receptor classification. Mol Pharmacol (1990) 1.27
BHIVA treatment guidelines for tuberculosis (TB)/HIV infection 2005. HIV Med (2005) 1.26
Expression of a human cDNA encoding the beta 2-adrenergic receptor in Chinese hamster fibroblasts (CHW): functionality and regulation of the expressed receptors. Mol Pharmacol (1988) 1.25